---
title: "EraCal Therapeutics Has Collaborated With Novo Nordisk To Develop And Commercialize EraCal's Oral, Small Molecule Program To Treat Obesity, For An Receive Upfront, Development, And Commercial Milestones Of Up To €235M"
description: "https://www.eracal.ch/_files/ugd/b8426d_f96f5439a98b4f2db3e0fa5f5ee1c570."
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/106555710.md"
published_at: "2024-01-23T16:59:32.000Z"
---

# EraCal Therapeutics Has Collaborated With Novo Nordisk To Develop And Commercialize EraCal's Oral, Small Molecule Program To Treat Obesity, For An Receive Upfront, Development, And Commercial Milestones Of Up To €235M

> https://www.eracal.ch/_files/ugd/b8426d_f96f5439a98b4f2db3e0fa5f5ee1c570.

https://www.eracal.ch/\_files/ugd/b8426d\_f96f5439a98b4f2db3e0fa5f5ee1c570.pdf

### Related Stocks

- [08426.HK - MODERN LIVING](https://longbridge.com/en/quote/08426.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | [Link](https://longbridge.com/en/news/276067278.md) |
| Tencent has a key advantage over other Chinese AI stocks: here's what it is | Tencent has a unique "trust advantage" in the competitive Chinese AI sector, according to Rupert Mitchell, a market obse | [Link](https://longbridge.com/en/news/276073565.md) |
| SADAFCO H2 Dividend Per Share Sar 8 | SAUDIA DAIRY & FOODSTUFF :SADAFCO- H2 DIVIDEND PER SHARE SAR 8 | [Link](https://longbridge.com/en/news/276059054.md) |
| REG - AIM - AIM Notice - 16/02/2026 | The London Stock Exchange has admitted several securities to trading on AIM as of February 16, 2026. The companies liste | [Link](https://longbridge.com/en/news/276041707.md) |
| A Piece Of The Puzzle Missing From Cosmos Insurance Company Public Ltd.'s (CSE:COS) 31% Share Price Climb | Cosmos Insurance Company Public Ltd. (CSE:COS) has seen a 31% increase in share price over the last month, despite a 23% | [Link](https://longbridge.com/en/news/275999303.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.